Skip to main content
  • Home
  • Individualising Antithrombotic Strategies for Established Coronary Artery Disease

Individualising Antithrombotic Strategies for Established Coronary Artery Disease

Topic:
  • Intervention

Available Credit:

  • 1.00 European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

Course Published On:

Course Expiry Date:

Individualising Antithrombotic Strategies for Established CAD

Overview

Radcliffe Medical Education bring together an expert panel to address the importance of providing individualised antithrombotic treatment in Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS). 

 

Chaired by Prof Marco Valgimigli (Instituto Cardiocentro Ticino, Lugano, CH), the panel review the two patient cases presented in phase one of this programme, present impactful new trial data and discuss practical solutions to common challenges experienced in real-world practice.

 

Further, the faculty review and summarise the new recommendations for antithrombotic treatment strategies in ACS and CCS patients with established coronary artery disease (CAD) made in the 2022 joint clinical consensus statement of the European Association of Percutaneous Coronary Intervention (EAPCI), Association for Acute Cardiovascular Care (ACVC) and European Association of Preventive Cardiology (EAPC).

Support Statement

This programme is supported by an unrestricted educational grant from AstraZeneca.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session, ‘Individualising Antithrombotic Strategies for Established Coronary Artery Disease’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionalsand the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 90 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • General Cardiologists
  • Interventional Cardiologists
  • Nurses
  • HCPs

Learning Objectives

Upon participation in this programme, physicians will be able to:

  • Summarise current guidance for choosing antithrombotic therapy in established CAD
  • Describe current gaps in clinical evidence and what is missing from current guidance
  • Adopt an evidence-based approach for managing patients with ACS and CCS
Register now Log in

Module

Title

Duration

Speakers

Presentation & Discussion Patient Cases Revisited 18 mins Eliano Navarese (Toruń, PL) Pascal Vranckx (Hasselt, BE)
Presentation Development of a Consensus for Antithrombotic Therapy in CAD 15 mins Marco Valgimigli (Lugano, CH)
Presentation Antithrombotic Treatment Strategies in Patients With Established CAD: Results of Two Network Meta-Analyses 15 mins Eliano Navarese (Toruń, PL)
Presentation Clinical Consensus Statements on Patients With ACS 15 mins Vijay Kunadian (Newcastle, UK)
Presentation Clinical Consensus Statements on Patients With CCS 10 mins Pascal Vranckx (Hasselt, BE)
Discussion Panel Discussion and Q&A 15 mins Marco Valgimigli (Lugano, CH) Vijay Kunadian (Newcastle, UK) Eliano Navarese (Toruń, PL) Pascal Vranckx (Hasselt, BE)
Presentation & Discussion.

Patient Cases Revisited

Duration: 18 mins

Speakers: Eliano Navarese (Toruń, PL) Pascal Vranckx (Hasselt, BE)

Presentation.

Development of a Consensus for Antithrombotic Therapy in CAD

Duration: 15 mins

Speakers: Marco Valgimigli (Lugano, CH)

Presentation.

Antithrombotic Treatment Strategies in Patients With Established CAD: Results of Two Network Meta-Analyses

Duration: 15 mins

Speakers: Eliano Navarese (Toruń, PL)

Presentation.

Clinical Consensus Statements on Patients With ACS

Duration: 15 mins

Speakers: Vijay Kunadian (Newcastle, UK)

Presentation.

Clinical Consensus Statements on Patients With CCS

Duration: 10 mins

Speakers: Pascal Vranckx (Hasselt, BE)

Chair

Marco Valgimigli

Istituto Cardiocentro Ticino, Lugano

Prof Marco Valgimigli is an Interventional Cardiologist and Deputy Chief of Cardiology at the Cardiocentro Ticino Institute in Lugano, Switzerland.

View full profile

Panelist

Eliano Navarese

Nicolaus Copernicus University, PL

Prof Eliano Navarese is associate Professor and Director of Research at the Cardiovascular Institute, Nicolaus Copernicus University, Poland and adjunct professor at University of Alberta, Canada.

View full profile

Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne, UK

Prof Vijay Kunadian is Personal Chair and Professor of Interventional Cardiology at Newcastle University. 

View full profile

Pascal Vranckx

University of Hasselt

Prof Pascal Vranckx is a Clinical Consultant in Interventional Cardiology and Medical Director of Cardiac Critical Care Services at the Hartcentrum Hasselt in Belgium, and Professor of Medicine at the University of Hasselt, Belgium.

View full profile

1.00 European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

Related Courses

Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation
  • 1.00 EBAC

Learning objectives

  • Recall the long-term outcomes of TEER from real-world and RCT data
  • Apply the results of real-world data to both simple and complex patients
  • Describe how TEER is being used to benefit a range of patients with MR
See more
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
  • 1 EBAC

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users
  • 1 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
Transcatheter Interventions Online - Session 3.4: Debates
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more